SoSTART
Start or STop Anticoagulants Randomised Trial
The main aim of this randomised controlled trial involving people with atrial fibrillation who have had a brain haemorrhage is to determine whether starting full dose oral anticoagulation is superior to avoiding oral anticoagulation for the prevention of all serious vascular events.
Chief Investigator: Rustam Al-Shahi Salman
Number and location of participating sites (by region/ country): UK 32 sites (pilot phase), up to 120 sites (main phase)
EudraCT number: 2016-004121-16
ISRCTN number: https://clinicaltrials.gov/ct2/show/NCT03153150
Funder: Chest Heart & Stroke Scotland
Start and End date
Of grant award: August 2016 – July 2018
Of recruitment:
Current Status: in set up
Website: http://www.sostart.ed.ac.uk
Contact Details:
Sponsor: ACCORD http://www.accord.ed.ac.uk/
Chief Investigator: Rustam Al-Shahi Salman, Centre for Clinical Brain Sciences (CCBS), FU303i, First Floor, Chancellor's Building, 49 Little France Crescent, Edinburgh. EH16 4SB. Tel +44 (0)131 465 9602. Email: Rustam.Al-Shahi@ed.ac.uk
Trial manager: Kasia Adamczuk Kasia.Adamczuk@ed.ac.uk
ECTU Involvement Statistics / Data base and/or randomisation service